Vanillyl Alcohol

Vanillyl Alcohol

SCHEMBL117402

CCCCOCCCC.COc1cc(CO)ccc1O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2B6 P20813 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTR1A P08908 1/20 0.52
TAAR1 Q96RJ0 2/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
MMP1 P03956 1/20 0.51
FOS P01100 1/20 0.50
TTR P02766 1/20 0.50
JUN P05412 1/20 0.50
NR3C1 P04150 1/20 0.50
HSD17B1 P14061 1/20 0.50
HSD17B2 P37059 1/20 0.50
LMNA P02545 1/20 0.50
GLA P06280 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vanillyl Alcohol SCHEMBL14358230 0.95 CYP1A2 (0.54) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Vanillyl Alcohol SCHEMBL117979 0.94 CYP1A2 (0.56) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Vanillyl Alcohol SCHEMBL4396135 0.93 CYP1A2 (0.50) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Vanillyl Alcohol SCHEMBL15272606 0.93 CYP1A2 (0.55) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Vanillyl Alcohol SCHEMBL3386819 0.93 CYP1A2 (0.55) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Vanillyl Alcohol SCHEMBL117923 0.91 TAAR1 (0.54) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Vanillyl Alcohol SCHEMBL4383901 0.88 CYP1A2 (0.54) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
SCHEMBL29191829 0.88 TAAR1 (0.59) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
SCHEMBL28304313 0.88 PTPN1 (0.53) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6
Alcohol SCHEMBL579347 0.87 PTPN1 (0.51) CYP3A4CYP1A2CYP2C8CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110149795-B cosmetic mixture 西姆莱斯股份公司 2023-10-03 CN claimed
CN-115721567-A Thermal wet tissue and preparation method thereof 芜湖悠派护理用品科技股份有限公司 2023-03-03 CN claimed
CN-115127399-A Tear agent with pure biological capsaicin as base material 吉林省利盾科技有限公司 2022-09-30 CN claimed
CN-110123671-B Skin care product used together with patch and preparation and use methods thereof 时垠(上海)生物科技有限公司 2022-04-12 CN claimed
CN-110025496-B Skin care product for promoting absorption and preparation method thereof 高洋 2022-02-01 CN claimed
CN-110067139-B Antibacterial heat-preservation fabric, manufacturing process thereof and down quilt using same 杭州康浩一家家居科技有限公司 2021-12-21 CN claimed
CN-113754520-A Preparation method of vanillyl alcohol butyl ether 滕州市天水生物科技有限公司 2021-12-07 CN claimed
CN-113576987-A Massage gel applied to wave instrument and preparation method thereof 广州丽亦健美容美体设备有限公司 2021-11-02 CN claimed
CN-113389055-A Cool or heat-sensitive microcapsule, nonwoven fabric and absorbent article 上海护理佳实业有限公司 2021-09-14 CN claimed
US-20210212983-A1 ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS CHICAGO ATLANTIC ADMIN, LLC 2021-07-15 US claimed
EP-0977554-B1 CONFECTIONERY COMPOSITIONS PROCTER & GAMBLE (US) 2004-06-16 EP claimed
EP-0977553-B1 THROAT SOOTHING COMPOSITIONS PROCTER & GAMBLE (US) 2003-09-10 EP claimed
US-6432441-B1 ENCAPSULATION OF ANALGESICS, EXPECTORANTS OR ANTITUSSIVE AGENTS WITHIN PHOSPHATIDES TO PROLONG DRUG DELIVERY THE PROCTER & GAMBLE COMPANY 2002-08-13 US claimed
US-6306429-B1 THROAT DROPS SUITABLE FOR RELIEF OF COUGH AND COLD SYMPTOMS THE PROCTER & GAMBLE COMPANY 2001-10-23 US claimed
EP-0977553-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP claimed
EP-0977554-A1 CONFECTIONERY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP claimed
WO-1998047483-A1 CONFECTIONERY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO claimed
WO-1998047482-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO claimed
EP-0837862-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1998-04-29 EP claimed
WO-1997002273-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1997-01-23 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210212983-A1 ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS CNR2, CNR1, CPNE4 CYP3A4 772/4885CYP1A2 1804/4885CYP2C8 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.